Last updated on August 2019

Study of NGM621 in Participants With Geographic Atrophy


Brief description of study

This is a multi-center evaluation of NGM621 in an open-label, single-dose and multiple-dose escalation study in participants with Geographic Atrophy secondary to Age-related Macular Degeneration.

Clinical Study Identifier: NCT04014777

Find a site near you

Start Over

NGM Clinical Study Site

Arcadia, CA United States
  Connect »

NGM Clinical Study Site

Newport Beach, CA United States
  Connect »

NGM Clinical Study Site

Melbourne, FL United States
  Connect »

NGM Clinical Study Site

Saint Petersburg, FL United States
  Connect »

NGM Clinical Study Site

Austin, TX United States
  Connect »

NGM Clinical Study Site

The Woodlands, TX United States
  Connect »